Mobile IV therapy in Florida: a provider and product checklist

A Florida mobile IV service is only as clear as its entire chain: evaluation, order, licensed professionals, finished product, pharmacy or manufacturer, transport, storage, treatment location, monitoring, emergency response, record, and follow-up. “Mobile,” “concierge,” or “IV certified” does not replace any link. Ask who owns each step before the bag travels to a home, hotel, office, or event.¹²³⁴

Mobility changes logistics, not the need to identify people, products, and responsibility. The person advertising the appointment may not be the evaluator, prescriber, administrator, pharmacy, records custodian, or clinician available after departure.

Map the mobile IV chain before discussing ingredients

Florida’s nursing chapter defines licensed roles and practice boundaries.¹ The state also has a specific rule addressing IV therapy by licensed practical nurses, with conditions that should not be generalized to every license, task, or setting.² Verify the individual in Florida’s public records and ask the service to explain the authority for the precise act—not simply whether someone completed an “IV certification” course.

Separate ordering, administering, and dispensing

These verbs are not interchangeable. An authorized clinician may evaluate and order; another licensed professional may administer under the applicable plan; a pharmacy or properly registered practitioner may dispense a patient-labeled product in circumstances governed by separate requirements.³ A bag being carried to an appointment does not explain which path supplied it.

Ask whether the product is:

• an FDA-approved finished drug used according to its labeling;
• an approved product used off label;
• a patient-specific compounded preparation;
• supplied under another lawful institutional or office process; or
• mixed at the treatment location.

For a compounded preparation, identify the path first. For 503A, record the licensed pharmacist or physician and identified-individual-patient prescription basis; for 503B, record the FDA-registered outsourcing facility and applicable office-order record. Then preserve the source name and address, state license, exact formula, label, lot, date, storage, and complaint contact. FDA explains that compounded drugs are not FDA approved and are not reviewed before marketing for safety, effectiveness, or quality in the same way as approved drugs.⁴ The compounding verification workflow can be applied without treating registration as approval.

Inspect the transport record

A mobile service should be able to preserve a chain from preparation or dispensing to administration. The useful record includes who packed it, seal condition, storage limits, time out of controlled storage, transport container, temperature evidence when required, patient match, visual inspection, and what happens after a deviation.

Do the same for add-on vials and supplies. The sterile-vial guide explains why single-dose versus multiple-dose labeling, puncture history, syringe reuse, and patient separation matter. A sealed tote is not itself proof of provenance or correct storage.

Treat the location as part of the plan

Before arrival, identify a private, clean, adequately lit place where the person can be positioned and observed. Ask how hand hygiene, skin preparation, supply setup, sharps disposal, blood or fluid spills, power or equipment needs, and other people or animals in the room are handled.

The response plan should name baseline observations, ongoing checks, symptoms or findings that stop the infusion, available supplies, who calls emergency services, what information travels with the person, and who follows up. This is not a prediction that a problem will occur; it is ordinary ownership planning when care leaves a fixed site.

Verify the visit in seven records

1. Capture the advertisement. Save the seller, package name, ingredients claimed, price, address coverage, and promises before checkout.
2. Name every professional. Record evaluator, prescriber, administrator, supervisor if applicable, license, employer, and real-time contact.
3. Read the exact order. Match patient, ingredients, concentration, volume, route, timing, and authorized changes.
4. Trace the product. Preserve manufacturer or pharmacy, label, lot, date, container, source status, transport, and storage.
5. Evaluate the address. Confirm privacy, setup, sanitation, monitoring, sharps, waste, and practical emergency access.
6. Assign response ownership. Name stop criteria, on-site response, escalation, transfer information, and the clinician available afterward.
7. Obtain the record. Know where the evaluation, order, administration details, observations, product identifiers, and follow-up note will be kept.

The decisive question is: “Who evaluated, ordered, supplied, transported, administered, monitored, documented, and remains responsible for this exact IV at this exact address?”